BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 19675999)

  • 21. Non-alcoholic fatty liver disease (NAFLD) potentiates autoimmune hepatitis in the CYP2D6 mouse model.
    Müller P; Messmer M; Bayer M; Pfeilschifter JM; Hintermann E; Christen U
    J Autoimmun; 2016 May; 69():51-8. PubMed ID: 26924542
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunohistopathological reactions for liver-specific membrane lipo-protein in experimental autoimmune hepatitis.
    Chattopadhyay D; Sen MR; Aryya NC
    Indian J Pathol Microbiol; 1999 Jul; 42(3):291-7. PubMed ID: 10862286
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The benefit of animal models for autoimmune hepatitis.
    Jaeckel E; Hardtke-Wolenski M; Fischer K
    Best Pract Res Clin Gastroenterol; 2011 Dec; 25(6):643-51. PubMed ID: 22117631
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LKM1-positive type 2 autoimmune hepatitis following allogenic hematopoietic stem-cell transplantation.
    Granito A; Stanzani M; Muratori L; Bogdanos DP; Muratori P; Pappas G; Quarneti C; Lenzi M; Vergani D; Bianchi FB
    Am J Gastroenterol; 2008 May; 103(5):1313-4. PubMed ID: 18477361
    [No Abstract]   [Full Text] [Related]  

  • 25. Autoimmune hepatitis, from mechanisms to therapy.
    Manns MP; Vogel A
    Hepatology; 2006 Feb; 43(2 Suppl 1):S132-44. PubMed ID: 16447290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathogenesis of autoimmune hepatitis.
    McFarlane IG
    Biomed Pharmacother; 1999 Jun; 53(5-6):255-63. PubMed ID: 10424247
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advances in the diagnosis, pathogenesis, and management of autoimmune hepatitis.
    Czaja AJ; Manns MP
    Gastroenterology; 2010 Jul; 139(1):58-72.e4. PubMed ID: 20451521
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autoantibodies directed against the UDP-glucuronosyltransferases in human autoimmune hepatitis.
    Fabien N; Desbos A; Bienvenu J; Magdalou J
    Autoimmun Rev; 2004 Jan; 3(1):1-9. PubMed ID: 14871643
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immune mechanisms of Concanavalin A model of autoimmune hepatitis.
    Wang HX; Liu M; Weng SY; Li JJ; Xie C; He HL; Guan W; Yuan YS; Gao J
    World J Gastroenterol; 2012 Jan; 18(2):119-25. PubMed ID: 22253517
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Marked changes of the hepatic sinusoid in a transgenic mouse model of acute immune-mediated hepatitis.
    Warren A; Bertolino P; Benseler V; Fraser R; McCaughan GW; Le Couteur DG
    J Hepatol; 2007 Feb; 46(2):239-46. PubMed ID: 17125874
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnosis and treatment of autoimmune hepatitis.
    Luxon BA
    Gastroenterol Clin North Am; 2008 Jun; 37(2):461-78, vii-viii. PubMed ID: 18499031
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autoimmune hepatitis: evolving concepts.
    Diamantis I; Boumpas DT
    Autoimmun Rev; 2004 Mar; 3(3):207-14. PubMed ID: 15110233
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-LC1 autoantibodies in patients with chronic hepatitis C virus infection.
    Béland K; Lapierre P; Marceau G; Alvarez F
    J Autoimmun; 2004 Mar; 22(2):159-66. PubMed ID: 14987745
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autoimmune hepatitis: are we using the right therapy?
    Murray KF
    J Pediatr Gastroenterol Nutr; 2007 Jan; 44(1):18-9. PubMed ID: 17204947
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinicopathologic features of the severe form of acute type 1 autoimmune hepatitis.
    Abe M; Onji M; Kawai-Ninomiya K; Michitaka K; Matsuura B; Hiasa Y; Horiike N
    Clin Gastroenterol Hepatol; 2007 Feb; 5(2):255-8. PubMed ID: 17218164
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Animal models of autoimmune hepatitis.
    Christen U
    Biochim Biophys Acta Mol Basis Dis; 2019 May; 1865(5):970-981. PubMed ID: 29857050
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulatory T Cells in Autoimmune Hepatitis: Unveiling Their Roles in Mouse Models and Patients.
    Wang H; Feng X; Yan W; Tian D
    Front Immunol; 2020; 11():575572. PubMed ID: 33117375
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transgenic mice expressing osteopontin in hepatocytes as a model of autoimmune hepatitis.
    Mochida S; Yoshimoto T; Mimura S; Inao M; Matsui A; Ohno A; Koh H; Saitoh E; Nagoshi S; Fujiwara K
    Biochem Biophys Res Commun; 2004 Apr; 317(1):114-20. PubMed ID: 15047155
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autoantibodies in Autoimmune Hepatitis: Can Epitopes Tell Us about the Etiology of the Disease?
    Christen U; Hintermann E
    Front Immunol; 2018; 9():163. PubMed ID: 29503645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autoimmune liver disease.
    Czaja AJ
    Curr Opin Gastroenterol; 2009 May; 25(3):215-22. PubMed ID: 19387256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.